- Citations, last 5 years
- 191
- Works, last 5 years
- 21
- h-index
- 37
- Scientists listed
- 3
- Grants since 2016
- 7
Grants received
2025–2028 · research · R44
Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia
Biree Andemariam · Hemanext (United States) · funded by National Institutes of Health
2024–2025 · research · R43
Hypoxically stored whole blood--evaluation of platelet activities under hypoxic storage conditions
Moritz Stolla · Hemanext (United States) · funded by National Institutes of Health
2020–2022 · research · R44
An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development.
Travis Nemkov · Hemanext (United States) · funded by National Institutes of Health
2020–2024 · research · R44
An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development.
Travis Nemkov · Hemanext (United States) · funded by National Institutes of Health
2016–2021 · research · R44
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage
Andrew Dunham · Hemanext (United States) · funded by National Institutes of Health
2016–2019 · research · R44
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage
Andrew Dunham · Hemanext (United States) · funded by National Institutes of Health
2016–2019 · research · R44
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage
Andrew Dunham · Hemanext (United States) · funded by National Institutes of Health